Previous work in Kenyan women found that successful BV treatment reduced the relative abundance of BV-associated bacteria and increased the relative abundance of L. iners 1 month after treatment (15); treatment also reduced vaginal proinflammatory cytokines but unexpectedly increased vaginal chemoattractant chemokines, such as IP-10 (15). Here, CXCL10 is linked to bacterial vaginosis.